Business

SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate

SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate

Synbiotic SeOctober 21, 20254
SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate

About this update from Synbiotic Se

SYNBIOTIC SE/ Key word(s): Statement SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate 21.10.2025 / 10:03 CET/CESTThe issuer is solely responsible for the content of this announcement.SYNBIOTIC welcomes Green Party’s proposal for the Industrial Hemp Liberalization Act and calls for objectivity in the medical cannabis debate The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN | WKN A3E5A5) considers the bill introduced by Bündnis 90/Die Grünen on 7 October 2025 to amend the Consumer Cannabis Act (KCanG) an important step towards greater legal certainty, innovation, and competitiveness for the German hemp industry. At the same time, the company is closely monitoring the planned tightening of the Medical Cannabis Act (MedCanG).Momentum for the hemp industry: liberalization of industrial hemp opens new perspectives The Greens’ proposal aims to remove the so-called “intoxication clause”, raise the THC limit for industrial hemp from 0.3% to 1%, and permit indoor cultivation. This would align Germany with practices already established in other EU countries such as the Czech Republic. The reform would significantly expand the economic scope for cultivation, processing, and product development within the industrial hemp sector. According to SYNBIOTIC, the proposed liberalization would represent an important impulse for sustainable agriculture, innovation, and regional value creation. The Group is well integrated across Europe and strongly positioned in the industrial hemp market through subsidiaries such as Hempro International, Hemp Factory, and Ilesol, and therefore sees significant potential to further develop hemp as a sustainable raw material for future industries. Daniel Kruse, CEO of SYNBIOTIC: “For decades, we have been advocating for evidence-based and innovation-driven hemp policies. The Greens’ initiative is a signal of progress and reinforces confidence in the future of industrial hemp. As President of the European Industrial Hemp Association (EIHA), entrepreneur of 30 years, and CEO of SYNBIOTIC, I hope that Federal Agriculture Minister Alois Rainer will recognize the enormous potential of this crop for agriculture, industry, and trade.”Criticism of the MedCanG reform: patient care must not suffer The draft bill presented by Federal Healt...

View stock analysis, news, and events for Synbiotic Se